| Page 1443 | Kisaco Research
Q&A: Roland Cloutier Chief Security Officer TikTok and ByteDance

Bacthera Q&A

Would you please introduce Bacthera?

Bacthera Q&A
 

Daniel Menichella

President and CEO
Kaleido Biosciences

Daniel Menichella

President and CEO
Kaleido Biosciences

Daniel Menichella

President and CEO
Kaleido Biosciences
 

Neil Schauer Ph.D

Principal Consultant
Schauer Biologics Consulting

Neil Schauer Ph.D

Principal Consultant
Schauer Biologics Consulting

Neil Schauer Ph.D

Principal Consultant
Schauer Biologics Consulting
Women's Health & the Journey Ahead
The Need for Knowledge and Action - Endometriosis
 

Bradley Evan

Assistant Professor
University of Massachusetts Chan Medical School

Dr Bradley emergency physician and clinical scientist with a focus on the interaction the microbiome and infectious diseases with the goal is of utilizing cutting edge technologies to address relevant clinical questions  that have the highest impact for changing current clinical practice. He is currently engaged in a study of the urinary microbiome to understand microbiome factors that are associated with pathogen colonization and factors that differentiate colonization from active infection.

Bradley Evan

Assistant Professor
University of Massachusetts Chan Medical School

Bradley Evan

Assistant Professor
University of Massachusetts Chan Medical School

Dr Bradley emergency physician and clinical scientist with a focus on the interaction the microbiome and infectious diseases with the goal is of utilizing cutting edge technologies to address relevant clinical questions  that have the highest impact for changing current clinical practice. He is currently engaged in a study of the urinary microbiome to understand microbiome factors that are associated with pathogen colonization and factors that differentiate colonization from active infection.

Recently his work has shifted to focus on COVID19 with funding through the Society for Academic Emergency Medicine. The oral microbiome is hypothesized to influence respiratory health, including how the immune system responds to respiratory viral infection such as influenza and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the pandemic Coronavirus Disease 2019 (COVID-19). In ongoing projects, he is investigating the association between the oral microbiome and acute COVID19 as well as the development of persistent symptoms, known as longCOVID.